Palvella Therapeutics (PVLA) Total Liabilities (2016 - 2023)
Historic Total Liabilities for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to $107.9 million.
- Palvella Therapeutics' Total Liabilities rose 27388.62% to $107.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $107.9 million, marking a year-over-year increase of 27388.62%. This contributed to the annual value of $11.4 million for FY2023, which is 8308.49% down from last year.
- According to the latest figures from Q3 2024, Palvella Therapeutics' Total Liabilities is $107.9 million, which was up 27388.62% from $105.9 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Total Liabilities registered a high of $110.3 million during Q3 2021, and its lowest value of $11.4 million during Q4 2023.
- Its 5-year average for Total Liabilities is $76.3 million, with a median of $74.0 million in 2020.
- In the last 5 years, Palvella Therapeutics' Total Liabilities tumbled by 8308.49% in 2023 and then skyrocketed by 27388.62% in 2024.
- Over the past 5 years, Palvella Therapeutics' Total Liabilities (Quarter) stood at $74.0 million in 2020, then surged by 38.96% to $102.8 million in 2021, then tumbled by 34.28% to $67.6 million in 2022, then crashed by 83.08% to $11.4 million in 2023, then surged by 844.4% to $107.9 million in 2024.
- Its last three reported values are $107.9 million in Q3 2024, $105.9 million for Q2 2024, and $106.4 million during Q1 2024.